Riskpilot← Back to searchSign inGet full accessSWEMAC ORTHOPAEDICS ApS
APSActiveCVR 29308276Lyngebæksgårdalle 2Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20062 employees
Revenue 2024
DKK 5,5M
+58% vs 2023
EBITDA margin
-5.0%
+39% vs 2023
Equity ratio
38.5%
Financial strength
Net profit 2024
DKK 2,5M
-19% vs 2023
| Revenue | DKK 5,5M | +58% |
| EBITDA | DKK -273K | +39% |
| Net profit | DKK 2,5M | -19% |
| Total assets | DKK 8,6M | +88% |
| Equity | DKK 3,3M | -13% |
| Employees | 2 | — |
Legal name
SWEMAC ORTHOPAEDICS ApS
CVR number
29308276
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. januar 2006
Share capital
DKK 125.000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse eller en direktør.
Company purpose
Selskabets formål er at drive handel og service navnlig inden for høreapparater, hjælpemidler og dermed beslægtet virksomhed.
Address
Lyngebæksgårdalle 2
Phone
+4545860028
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 618 | -24 | 82 | — | 2 | -35 | -22 | -26 | 471 | 1.493 | 2.740 | 3.487 | 5.514 |
| Staff expenses | -728 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -493 | -1.532 | -3.363 | -3.932 | -5.788 |
| EBITDA | -110 | -24 | 82 | -28 | 2 | -35 | -22 | -26 | -22 | -39 | -623 | -444 | -273 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -12 | -23 | -27 | -43 |
| EBIT | -110 | -24 | 82 | -28 | 2 | -35 | -22 | -26 | -22 | -51 | -647 | -471 | -316 |
| Net financials | 5.088 | 3.090 | 4.086 | 3.799 | 3.108 | 3.552 | 4.509 | 3.990 | 3.181 | 4.742 | 4.684 | 3.499 | 2.754 |
| Profit before tax | 4.978 | 3.066 | 4.167 | 3.771 | 3.110 | 3.518 | 4.487 | 3.963 | 3.158 | 4.691 | 4.037 | 3.028 | 2.439 |
| Tax | -18 | 25 | 33 | -4 | 3 | -1 | 11 | 7 | 6 | -8 | -125 | -80 | -67 |
| Net profit | 4.995 | 3.041 | 4.135 | 3.775 | 3.107 | 3.519 | 4.476 | 3.957 | 3.153 | 4.698 | 4.162 | 3.108 | 2.505 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 4.495 | 3.418 | 1.763 | 3.028 | 2.087 | 4.042 | 5.005 | 6.032 | 6.332 | 7.834 | 5.741 | 4.579 | 8.603 |
| Equity | 335 | 409 | 509 | 493 | 507 | 4.026 | 4.979 | 4.499 | 3.718 | 5.269 | 4.697 | 3.805 | 3.310 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 4.160 | 3.010 | 1.254 | 2.535 | 1.580 | 16 | 26 | 1.533 | 2.613 | 2.561 | 1.033 | 768 | 5.279 |
| Total debt | 4.160 | 3.010 | 1.254 | 2.535 | 1.580 | 16 | 26 | 1.533 | 2.613 | 2.561 | 1.033 | 768 | 5.279 |
EBITDA margin
-5.0%
This company
15.8%
Market median
-132% vs market
20122024
Equity ratio
38.5%
This company
38.2%
Market median
+1% vs market
20122024
Return on equity
75.7%
This company
18.4%
Market median
+311% vs market
20122024
Net profit margin
45.4%
This company
8.1%
Market median
+460% vs market
20122024
Asset turnover
0.64×
This company
1.12×
Market median
-43% vs market
20122024
Debt / equity
1.60×
This company
0.62×
Market median
-158% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BE Management | Management | 2006 | — | — |
JS | Audit | 2006 | — | — |
JH Management | Management | 2006 | — | — |
MS Chief Executive Officer | Chief Executive Officer | 2008 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2018 | — | — | |
| Chairman | 2006 | — | — | |
| Chairman | 2006 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2006 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SWEMAC ORTHOPAEDICS ApS 
SWEMAC OSMEDIC ApSBoard members of SWEMAC ORTHOPAEDICS ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bjarke Enevold Jørgensen | Management | 0 companies |
| Judith Schack Rasmussen | Audit | 0 companies |
| Jørgen Herman Melchior | Management | 0 companies |
| Martin Sjögren | Chief Executive Officer | 0 companies |
| Henrik Hansson | Chairman | 0 companies |
| Christer Lundkvist | Chairman | 0 companies |
| Peter Andreas Stakemann | Chairman | 0 companies |